Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure–Activity Relationships and Discovery Strategies To Mitigate Drug–Drug Interaction Risks
-
- Dennis O. Scott
- Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, 620 Memorial Drive, Cambridge, Massachusetts 02139, United States
-
- Amit S. Kalgutkar
- Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, 620 Memorial Drive, Cambridge, Massachusetts 02139, United States
収録刊行物
-
- Journal of Medicinal Chemistry
-
Journal of Medicinal Chemistry 55 (11), 4896-4933, 2012-03-27
American Chemical Society (ACS)
